IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
19 hedge funds and large institutions have $2.98M invested in Interpace Biosciences, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$14K | |
| 2 | +$11.8K | |
| 3 | +$2.23K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$111 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$111 |
Top Sellers
| 1 | -$195K | |
| 2 | -$112K | |
| 3 | -$50.1K | |
| 4 |
MA
Minerva Advisors
Bala Cynwyd,
Pennsylvania
|
-$41K |
| 5 |
ANTB
AMG National Trust Bank
Greenwood Village,
Colorado
|
-$39K |